Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CR.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XANSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EW.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.26.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.10.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CL.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.7 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.6.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.620SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.1 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used